V H Yuen1, P J Dolman. Show Affiliations » 1. Department of Ophthalmology, University of British Columbia, Vancouver.
Abstract
Entities: Disease
Mesh： See more » AgedBlepharoplastyBlepharoptosis/complicationsBlepharoptosis/surgeryDrug Therapy, CombinationFemaleFibrinolytic Agents/adverse effectsFollow-Up StudiesHeparin/adverse effectsHumansMyocardial Infarction/complicationsMyocardial Infarction/drug therapyPostoperative Hemorrhage/chemically inducedPostoperative Hemorrhage/surgeryRetrobulbar Hemorrhage/chemically inducedRetrobulbar Hemorrhage/surgerySuctionThrombolytic Therapy/adverse effectsTissue Plasminogen Activator/adverse effectsVisual Acuity
Substances： See more » Fibrinolytic AgentsHeparinTissue Plasminogen Activator
Year: 1999 PMID： 10088061
Source DB: PubMed Journal: Can J Ophthalmol ISSN： 0008-4182 Impact factor: 1.882